The largest database of trusted experimental protocols

Vetorphale

Manufactured by Meiji Seika Pharma
Sourced in Japan

Vetorphale is a laboratory equipment designed for the separation and analysis of peptides and proteins. It utilizes a specialized chromatography technique to isolate and purify these biomolecules from complex samples. The core function of Vetorphale is to provide researchers and scientists with a reliable and efficient tool for the study of peptides and proteins, which are essential components in various biological and pharmaceutical applications.

Automatically generated - may contain errors

85 protocols using vetorphale

1

Reparative Dentin Formation in Tooth Replantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two- and three-week-old animals were used for tooth replantation, which were referred to as 2W and 3W groups, respectively to clarify the role of OPN in the process of reparative dentin formation following tooth replantation using the unerupted teeth with short roots in the 2W group as well as the erupted teeth with long roots in the 3W group. The upper right first molars (M1) of Opn KO and WT mice were extracted under deep anesthesia following an intraperitoneal injection of a mixed solution (0.05–0.1 mL/10 g) of Domitor® (1.875 mL: Nippon Zenyaku Kogyo Co, Ltd, Koriyama, Japan), midazolam (2 mL: Sandoz KK, Tokyo, Japan), Vetorphale® (2.5 mL: Meiji Seika Pharma Co, Ltd, Tokyo, Japan), and physiological saline (18.625 mL), using a pair of modified dental tweezers. The tooth was immediately repositioned in the original socket. The animals were divided into four groups: Opn KO 2W, Opn KO 3W, WT 2W, and WT 3W groups.
+ Open protocol
+ Expand
2

Anesthetic Protocol for Blood Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected into sampling tubes under deep intraperitoneal anesthesia with an anesthetic mixture of three drugs: medetomidine (Domitor, Nippon Zenyaku Kogyo Co., Ltd., Tokyo, Japan), midazolam (dormicum, AstelllasPharma INC., Tokyo, Japan), and butorphanol (Vetorphale, Meiji Seika Pharma Co., Ltd., Tokyo, Japan). We conducted the anesthesia in accordance with our previous studies (Arauchi et al., 2017 ). Medetomidine 0.15 mg, midazolam 2 mg, and butorphanol 2.5 mg/kg b.w./rat were mixed and added to saline (Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan) to adjust the mixture to a volume of 0.5 ml/100 g b.w./rat. The blood samples were centrifuged at 2500 g for 20 min. Samples were stored at -80 °C until the day of analysis.
+ Open protocol
+ Expand
3

Multi-region Viral Tracing in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the previously reported method with some modification59 (link). Mice were deeply anesthetized with medetomidine hydrochloride (0.3 mg/kg, Domitol, Meiji Seika Pharma), midazolam (4 mg/kg, Dormicum, Astellas Pharma) and butorphanol (5 mg/kg, Vetorphale, Meiji Seika Pharma), and the head of the mice was fixed in a stereotaxic apparatus (SR-5M-HT, Narishige). rAAV solutions were unilaterally injected (approximately 250 nl in one site) into the ACC [rostrocaudal (RC): +1.0 mm, mediolateral (ML): 0.3 mm, dorsoventral (DV): 0.8 mm], CLA [RC: +1.0 mm, ML: 2.8 mm, DV: 3.5 mm], IC [RC: +1.0 mm, ML: 3.3 mm, DV: 3.5 mm], and ventrolateral Striatum [RC: +1.0 mm, ML: 2.3 mm, DV: 3.5 mm]. Retrobeads (10% dilution, 300 nl, 1RX, LUMAFLUOR) were unilaterally injected into the ACC or CLA. We used virus-injected mice 3 weeks or more after the last injection of AAV vectors and Retrobeads-injected mice 1‒2 weeks after the injection for further analysis.
+ Open protocol
+ Expand
4

Rat Brain Perfusion and Cryoprotection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals underwent deep intraperitoneal anesthesia with an anesthetic mixture of three drugs: medetomidine (Domitor, Nippon Zenyaku Kogyo, Tokyo, Japan), midazolam (Dormicum, AstellasPharma, Tokyo, Japan), and butorphanol (Vetorphale, Meiji Seika Pharma, Tokyo, Japan). We mixed medetomidine 0.15 mg, midazolam 2 mg, and butorphanol 2.5 mg/kg b.w./rat and added saline (Otsuka Pharmaceutical Factory, Tokushima, Japan) to adjust the mixture to a volume of 0.5 ml/100 g b.w./rat. The rats were perfused transcardially with saline, followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB). The brains were taken out and were fixed with 4% PFA in 0.1 M PB at room temperature (RT) for 4 hr. The brains were immersed in 10% sucrose at 4°C overnight and subsequently were immersed in 20% sucrose at 4°C for 3 days. The brains were cut at 40 μm thickness with a freezing microtome (Microm HM 430; Thermo Scientific, Germany).
+ Open protocol
+ Expand
5

Anesthesia Cocktails for Rodent Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Avertin: 2,2,2-Tribromoethanol (2%, Sigma-Aldrich, St. Louis, MO, USA), 100% ethanol (8%,
Wako Pure Chemical Industries Osaka, Japan), and 2-Methyl-2-butanol (1.2%, Wako Pure
Chemical Industries) were dissolved in 0.9% sterile NaCl.
3MIX: Medetomidine (0.003%, Domitor, Nippon Zenyaku Kogyo Co., Ltd., Koriyama, Japan),
midazolam (0.04%, Dormicum, Astellas Pharma Inc., Tokyo, Japan), and butorphanol tartrate
(0.05%, Vetorphale, Meiji Seika Pharma Co., Ltd., Tokyo, Japan) were dissolved in 0.9%
sterile NaCl.
+ Open protocol
+ Expand
6

Syrian Hamster SARS-CoV-2 Infection Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Syrian hamsters (male, 4 weeks old) were purchased from Japan SLC Inc. (Shizuoka, Japan). Baseline body weights, respiratory parameters, and SpO2 were measured before infection. For the virus infection experiments, hamsters were euthanized by intramuscular injection of a mixture of 0.15 mg/kg medetomidine hydrochloride (Domitor®, Nippon Zenyaku Kogyo), 2.0 mg/kg midazolam (Dormicum®, FUJIFILM Wako Chemicals), and 2.5 mg/kg butorphanol (Vetorphale®, Meiji Seika Pharma) or 0.15 mg/kg medetomidine hydrochloride, 2.0 mg/kg alphaxaone (Alfaxan®, Jurox), and 2.5 mg/kg butorphanol. The B.1.1 virus, Omicron subvariants (5 × 1000 TCID50 in 100 µl), and saline (100 µl) were intranasally inoculated under anesthesia. Oral swabs were collected at the indicated timepoints. Body weight was recorded daily by 7 d.p.i., and at 10 and 14 d.p.i. Enhanced pause (Penh, see below), the ratio of time to peak expiratory flow relative to the total expiratory time (Rpef, see below), and subcutaneous oxygen saturation (SpO2, see below) were monitored on 1, 3, 5, and 7 d.p.i. Lung tissues were collected at 2 and 5 d.p.i. Viral RNA load in the oral swabs and respiratory tissues was determined by RT-qPCR. Viral titers in the lung periphery were determined using TCID50. These tissues were also used for histopathological and IHC analyses (see below).
+ Open protocol
+ Expand
7

Multimodal Anesthesia Protocols for Mouse Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Medetomidine (Dorbene Vet, Kyoritsu Seiyaku, Co., Tokyo, Japan), midazolam (Midazolam
Sandoz, Sandoz Japan Co., Ltd., Tokyo, Japan), Butorphanol (Vetorphale, Meiji Seika Pharma
Co., Ltd., Tokyo, Japan), and alfaxalone (Alfaxan, Meiji Seika Pharma Co., Ltd.) were used
in the combinations listed in Table
1
Summary of the drugs and doses used in this study
AbbreviationProductProduct concentration(mg/ml)Agent dose(mg/kg)Volume in 10 mlnormal
saline (ml)
MMBMedetomidine10.30.3
Midazolam540.8
Butorphanol551
0.9% NaCl--7.9

0.5MBA30Medetomidine10.50.5
Butorphanol551
Alfaxalone10303
0.9% NaCl--5.5

0.75MBA30Medetomidine10.750.75
Butorphanol551
Alfaxalone10303
0.9% NaCl--5.25

0.75MBA40Medetomidine10.750.75
Butorphanol551
Alfaxalone10404
0.9% NaCl--4.25
. The drugs were diluted in normal saline (0.9% NaCl) to concentrations that
could be administered in a total volume of 0.01 ml/g of body weight. MMB
comprised 0.3 mg/kg Medetomidine, 4 mg/kg midazolam, and 5 mg/kg Butorphanol. Other groups
of mice were administered 0.5 mg/kg Medetomidine and 5 mg/kg Butorphanol with 30 mg/kg
alfaxalone (0.5MBA30), or 0.75 mg/kg Medetomidine and 5 mg/kg Butorphanol with 30 mg/kg
(0.75MBA30) or 40 mg/kg (0.75MBA40) alfaxalone.
+ Open protocol
+ Expand
8

Epigenetic Regulation of Npas4 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CGRP or saline was administered i.c.v. for 24 hr before cross-linking. The mice were deeply anesthetized with three types of mixed anesthetic agents (49) , medetomidine hydrochloride (Domitol, Meiji Seika Pharma Co., Ltd., Tokyo, Japan, 0.3 mg/kg), midazolam (Dormicum, Astellas Pharma Inc., Tokyo, Japan, 4.0 mg/kg), and butorphanol (Vetorphale, Meiji Seika Pharma Co., Ltd., 5.0 mg/kg), administered intraperitoneally and perfused transcardially with saline, followed by 1% paraformaldehyde, pH 7.4. The hippocampus was post-fixed for 10 min in 1% paraformaldehyde, and then glycine (330 mM) was added. The chromatin was then sheared into approximately 0.5-1-kb fragments and immunoprecipitated using an anti-HDAC5 antibody (1:100 for the hippocampal sample, Santa Cruz Biotechnology), acetylated Histone3 antibody (1:100, Abcam plc) or Histone3 antibody (1:100, Abcam plc). Immunoprecipitated DNA fragments were amplified and quantitated by qPCR (Eco Real-Time PCR System (Illumina Inc.), using PCR primers specific for Npas4, which were designed around the putative enhancer regions of Npas4 (Table 2).
+ Open protocol
+ Expand
9

Wistar-Imamichi Rat Breeding Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult male and female Wistar–Imamichi rats for breeding were purchased from the Institute for Animal Reproduction (Ibaraki, Japan). Offspring derived from mating in our facility were housed with dams in the same cages until weaning at three weeks of age. After 8–10 weeks of age, female rats were confirmed to exhibit at least two standard four-day estrous cycles by daily vaginal smears. All animals were bred and housed in a room with a controlled temperature (24 ± 2 °C) and a 14-h light/10-h dark cycle (lights on 06:00 h). Standard diet and tap water were available ad libitum. All animals were euthanized under deep anesthesia by intraperitoneal injection of sodium pentobarbital (64.8 mg/kg body weight) and butorphanol (2.5 mg/kg body weight, Vetorphale, Meiji Seika Pharma, Tokyo, Japan). The time periods for euthanasia ranged from 15:00 to 18:00 h. All animal experimental procedures were approved by the Committee on the Care and Use of Experimental Animals of Nippon Medical School and were conducted in compliance with Guidance on Animal Bioethics (based on the guidelines for humane treatment of experimental animals issued by the US National Institutes of Health) of Nippon Medical School (permit number 27-173; approved 22 June 2015).
+ Open protocol
+ Expand
10

Implantation of Bone Cement Composites in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vivo studies were approved by the Kitasato University School of Medicine and Hospital Ethics Committee (Approval number 2017-098). Wistar rats, 10 weeks old, were anesthetized with 0.3 mg/kg medetomidine (Domitor, Nippon Zenyaku Kogyo, Fukushima, Japan), 0.5 mg/kg butorphanol (Vetorphale, Meiji Seika Pharma, Tokyo, Japan), and 0.5 mg/kg midazolam (Midazolam Sandoz, Sandoz, Tokyo, Japan). CPC/VCM and PMMA/VCM were implanted between the fascia and the muscle of the femur on the left and right side of 40 rats, respectively. The fascia and skin were sutured and the animals were allowed to move freely in their cages immediately after the surgery. Test specimens were removed on days 1, 7, 28, and 56, after sacrificing the animals (n = 10 each).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!